The Global Multi-omics Solution for Precision Oncology
Access ethically sourced, clinically annotated human biospecimens, including longitudinal plasma and tissue formats. Accelerate your drug discovery with samples optimized for multi-omics and precision medicine.
High-Quality Human Biospecimens
The original company was founded in 2002 by leading scientists with a drive to revolutionize cancer treatment through individualized therapy. As an integrated global oncology company our clients leverage the highest quality biobank and state-of-the-art multiomics services to develop a true picture of cancer. We are headquartered in Hamburg, Germany, with a US-based subsidiary in Frederick, Maryland, USA and a global clinical network.
We are united by a shared responsibility:
Using our unique expertise and skill sets to work toward individualized cancer diagnosis and treatment for every patient.
Precision-Sourced Samples for Decision-Ready Data
Success in translational research begins with the quality of the starting material. We provide a diverse inventory of human biospecimens that bridge the gap between the lab and the clinic. Every sample is collected under strict protocols to ensure the preservation of biomarkers, allowing you to move forward with confidence in your genomic and proteomic signatures.
Comprehensive Biospecimen Services
The primary challenge in modern drug discovery is the scarcity of ethically sourced human biospecimens that maintain molecular integrity while providing deep clinical context. Traditional biobanking often suffers from fragmented data and inconsistent collection protocols, leading to “noisy” experimental results and failed biomarker validation.
We addresses these critical bottlenecks by providing a high-fidelity repository designed for precision analysis. We minimize sample variability through standardized, ultra-short cold ischemia protocols that preserve sensitive RNA, DNA, and protein signatures.
By integrating these high-quality tissues with comprehensive Immunohistochemistry (IHC) services, we provide researchers with a dynamic window into protein expression and spatial biology. Our samples include full clinical annotation—such as treatment history and pathological confirmation—enabling high-resolution insights into disease progression and drug resistance.
Discover Our Broad Range of Lab Services
IHC (Immunohistochemistry)
IHC (Immunohistochemistry)
Multiplex Fluorescent IHC Assay Development/ Validation and Digital Pathology on site
Genomics
Proteomics
Proteomics
Simple Western Technology and Cell Biology services as well as ex vivo assays
Key Differentiators
Each sample includes deep clinical annotation, including treatment history, demographics, and pathological confirmation.
Optimized collection protocols with ultra-short cold ischemia times to preserve RNA, DNA, and protein quality for NGS applications.
End-to-end solutions for the ethical collection, preservation, and characterization of high-quality biological specimens.
Specialized Solutions
Longitudinal Plasma and Liquid Biopsy Solutions
Tracking disease progression requires more than a snapshot. Our longitudinal plasma collections offer a window into the evolution of cancer, providing serial samples from the same patient across various treatment milestones. This is an essential resource for researchers developing non-invasive diagnostics or monitoring drug resistance mechanisms.
Quality and Compliance
All biospecimens are ethically sourced through a global network of clinical partners. Our samples are IRB-approved, fully traceable, and compliant with HIPAA and GDPR regulations. We prioritize donor privacy and data integrity, providing you with the peace of mind that your research meets the highest global ethical standards.
A Comprehensive Repository of High-Fidelity Biospecimens
Our inventory is curated to meet the rigorous demands of modern genomic and proteomic analysis. We offer a vast selection of high-quality human biospecimens, ranging from FFPE blocks and fresh-frozen tissues to specialized biofluids and primary cells.
Each specimen is meticulously characterized to ensure researchers have access to specific patient cohorts, including rare indications and diverse treatment backgrounds. By providing immediate access to diverse, well-documented samples, we eliminate the delays of prospective collection, allowing you to validate biological targets and assess biomarker prevalence with unprecedented speed and precision.
Find the Right Samples for Your Study
Search our inventory or request a custom collection tailored to your specific inclusion/exclusion criteria. Our team of scientists is ready to help you select the ideal cohorts for your next project.